Teneligliptin Hydrobromide Yepakati CAS 401564-36-1 Kuchena > 99.5% (HPLC) Factory
Supply Teneligliptin Hydrobromide Inoenderana Nepakati Nepamusoro Kuchena
Teneligliptin Hydrobromide CAS 906093-29-6
1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazine CAS 401566-79-8
Teneligliptin Hydrobromide Yepakati CAS 401564-36-1
| Chemical Name | (2S) -4-Oxo-2-(3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester |
| Mashoko anoreva zvakafanana | (S)-tert-Butyl 4-oxo-2-(thiazolidine-3-carbonyl)pyrrolidine-1-carboxylate;3-((S) -1-tert-butoxycarbonyl-4-oxo-2-pyrrolidinylcarbonyl) -1,3-thiazolidine;(2S) -4-oxo-2-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidine-1-carboxylate;Teneligptin Yepakati B |
| Nhamba yeCAS | 401564-36-1 |
| Nhamba yeCAT | RF-1818 |
| Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
| Molecular Formula | C13H20N2O4S |
| Molecular Weight | 300.37 |
| Density | 1.305 |
| Brand | Ruifu Chemical |
| Item | Inspection Standard | Results |
| Chitarisiko | Muchena kune Cream Colored Solid | Conform |
| Identification | IR;HPLC RT | Conform |
| Kurasika paKuomesa | <1.00% | 0.20% |
| Related Substances | Chero Kusachena Kumwechete <0.50% | 0.24% |
| Kusachena Kwese <0.50% | 0.39% | |
| Assay | 99.5% ~ 102.0% (Pamusoro Wakaoma) | 99.8% |
| Enantiomeric Purity | >99.5% | 99.9% |
| Sulfated Ash | <0.20% | 0.02% |
| Test Standard | Enterprise Standard | |
| Usage | Pakati peTeneligliptin Hydrobromide (CAS: 906093-29-6) | |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
(2S) -4-Oxo-2- (3-thiazolidinylcarbonyl) -1-pyrrolidinecarboxylic acid tert-butyl ester (CAS: 401564-36-1) inzvimbo yepakati inoshandiswa kugadzira dipeptidyl peptidase IV (DPP-IV) inhibitor, pakati. yeTeneligliptin Hydrobromide (CAS: 906093-29-6).Teneligliptin ndeye DPP-4 inhibitor yakabvumidzwa muJapan muna 2012 kurapa chirwere cheshuga chechipiri.Yakawanikwa uye yakagadziridzwa naMitsubishi Tanabe Pharma pasi pezita rekutengesa Tenelia®.Zvakafanana nezvimwe zvakashambadzirwa DPP-4 inhibitors, Teneligliptin yakatenderwa muzvidzidzo zvese uye QD dosing yakagadzira inogara kwenguva refu inhibitory chiito ichipokana neDPP-4 uye kuwedzera kweanoshanda GLP-1 mazinga, aine yakaderera zvakanyanya yerenal excretion.
